about
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infantsThe effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infantsWillingness to Know the Cause of Death and Hypothetical Acceptability of the Minimally Invasive Autopsy in Six Diverse African and Asian Settings: A Mixed Methods Socio-Behavioural Study.Current status of the clinical development and implementation of paediatric artemisinin combination therapies in Sub-Saharan Africa.Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials.A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children.Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura.Seroprevalence of Toxocara spp. in a rural population in Central African Gabon.Urogenital schistosomiasis during pregnancy is associated with low birth weight delivery: analysis of a prospective cohort of pregnant women and their offspring in Gabon.Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries.First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative.Preliminary Evidence for the Absence of Cystic Echinococcosis in Gabon: A Cross-Sectional Pilot Survey in Humans and Definitive Hosts.Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study
P50
Q28278852-31ABB13A-3834-4E18-A2CA-4FA558959279Q35105075-024CE1F4-8DC3-4F25-BF8D-11BA0678ABB2Q36201016-49111E36-AA1B-4DDF-9744-F71040B5CC32Q37914032-8F97505B-B84E-4D10-9749-A036EAA0A5C8Q38558100-DF125F53-8DC2-4A6B-A986-82B2157905F8Q38924537-EDC28008-34EF-4AD7-853B-604F27F8043CQ38995073-320790A5-9951-487B-80C0-49B09D380CB3Q39197276-79B9CE13-2427-4F77-86FB-519BACECA6E6Q39261935-5A4D9311-4D67-42A6-9464-96097C6BFA36Q43032696-374FCD51-894A-4A5F-A670-76C14B6072ECQ46182948-7BBC2315-E737-4026-AD59-A30863B46ECEQ49269944-BF55150E-526C-4624-A88E-9DF937AA2310Q54203231-1B92AA94-3689-4939-BDF9-43C1F87525F6Q59349574-514EE994-C31F-4718-B2DA-59E7219F47EB
P50
name
Selidji Todagbe Agnandji
@ast
Selidji Todagbe Agnandji
@en
Selidji Todagbe Agnandji
@es
Selidji Todagbe Agnandji
@nl
type
label
Selidji Todagbe Agnandji
@ast
Selidji Todagbe Agnandji
@en
Selidji Todagbe Agnandji
@es
Selidji Todagbe Agnandji
@nl
prefLabel
Selidji Todagbe Agnandji
@ast
Selidji Todagbe Agnandji
@en
Selidji Todagbe Agnandji
@es
Selidji Todagbe Agnandji
@nl